Introduction Frequent assessments of rheumatoid arthritis (RA) disease activity allow timely
adaptation of therapy, which is essential in preventing disease progression. However …

Introduction Clinical trials of new treatments for rheumatoid arthritis (RA) typically require
subjects to have an elevated acute phase reactant (APR), in addition to tender and swollen …

Objectives Disease Activity Score in 28 joints calculated with C-reactive protein (DAS28-
CRP) is used instead of erythrocyte sedimentation rate (DAS28-ESR) to assess rheumatoid …

Objective To compare nine disease activity indices and the new American College of
Rheumatology (ACR)/European League against Rheumatism (EULAR) remission criteria in …

Objective Several composite scores are available to assess the activity of rheumatoid
arthritis (RA). Criteria for remission and active RA based on these continuous scores are …

Objective Thresholds of minimal clinically important improvement (MCII) are needed to plan
and interpret clinical trials. We estimated MCIIs for the rheumatoid arthritis (RA) activity …

Aim: To examine the test–retest reliability of the rheumatoid arthritis (RA) core disease
activity measures and derived composite indices. Methods: A total of 28 stable patients with …

Objective: To validate and compare the definition of the Disease Activity Score 28 based on
C-reactive protein (DAS28 (CRP)) to the definition based on erythrocyte sedimentation rate …

Objective Although the systematic measurement of disease activity facilitates clinical
decision making in rheumatoid arthritis (RA), no recommendations currently exist on which …

The Disease Activity Score (DAS), its modified version the DAS28, and the DAS-based
European League Against Rheumatism (EULAR) response criteria are well-known …